Search Results - "Večeřová, L"

Diagnosis of minimal breast cancers by Večeřová, L, Bendová, M

“…This is a retrospective study evaluating the minimum detection cancers in the group of women mammographically examined in our department. The study covers the…”
Get more information

Cooperation between mammologist and radiodiagnostic in the management of mammary leasions in the University Hospital Kralovské Vinohrady by Bendová, M, Malina, R, Gojiš, O, Večeřová, L, Zemanová, G

“…Epidemiological datas describing up to date status of diagnostics and oncological parameters (incidence, mortality, prevalence, total number of pacients with…”
Get more information

AHR and ARNT expression in the human and rat placentas and their transcription activity in human trophoblast cultures in transactivation AHR battery genes by Stejskalová, L., Vecerova, L., Vrzal, R., Dvorak, Z., Nachtigal, P., Pávek, P.

Get full text

409 CHANGES OF ENDOGLIN LEVELS IN SERUM AND MICE AORTA WITH RESPECT TO CHOLESTEROL AND ATORVASTATIN by Večeřová, L., Strasky, Z., Rathouska, J., Slanarova, M., Brcakova, E., Nachtigal, P.

Get full text

MS38 ATORVASTATIN EFFECTS ON LIPID PROFILE IN ApoE/LDLR-DEFICIENT MICE by Slanařová, M., Večeřová, L., Stráský, Z., Tichá, A., Hyšpler, R., Nachtigal, P.

Get full text

Endoglin co-expression with eNOS, SMAD2 and phosphorylated SMAD2/3 in normocholesterolemic and hypercholesterolemic mice: an immunohistochemical study by Nachtigal, P, Vecerova, L, Pospisilova, N, Micuda, S, Brcakova, E, Navarro Hernandez, E, Pospechova, K, Semecky, V

“…Endoglin, a homodimeric transmembrane glycoprotein, is a part of the transforming growth factor-beta (TGF-beta) receptor cascade. It has been demonstrated that…”
Get full text

Abstract: P181 ENDOGLIN EXPRESSION IN ATHEROGENESIS AND AFTER ATORVASTATIN TREATMENT IN APOE/LDLR-DEFICIENT MICE by Nachtigal, P, Vecerova, L, Micuda, S, Brcakova, E, Solichova, D

Get full text

95 ATORVASTATIN INCREASES CHOLESTEROL LEVELS IN APOE/LDLR-DEFICIENT MICE by Slanarova, M., Brcakova, E., Vecerova, L., Strasky, Z., Rathouska, J., Hyspler, R., Ticha, A., Nachtigal, P.

Get full text

418 ENDOGLIN-RELATED PATHWAYS ARE NOT RELATED TO DISTINCT PREDISPOSITION TO ATHEROSCLEROSIS IN C57BL/6J AND C3H/HEJ MICE by Rathouska, J., Strasky, Z., Vecerova, L., Brcakova, E., Slanarova, M., Nachtigal, P.

Get full text

P424 ENDOGLIN (TYPE III TGF-β1 RECEPTOR), BAD OR GOOD IN ATHEROSCLEROSIS? by Nachtigal, P., Strasky, Z., Vecerova, L., Brcakova, E., Slanarova, M., Rathouska, J., Micuda, S.

Get full text

P412 PLEIOTROPIC EFFECTS OF ATORVASTATIN AND TGF-β/ENDOGLIN CASCADE IN THE VESSEL WALL OF ApoE/LDLR DOUBLE KNOCKOUT MICE by Strasky, Z., Vecerova, L., Slanarova, M., Rathouska, J., Brcakova, E., Micuda, S., Nachtigal, P.

Get full text

P407 ENDOGLIN EXPRESSION IN ATHEROGENESIS IS NOT RELATED TO EITHER CHOLESTEROL LEVELS OR PLAQUE SIZE IN ApoE/LDLR DOUBLE KNOCKOUT MICE by Vecerova, L., Strasky, Z., Rathouska, J., Slanarova, M., Brcakova, E., Micuda, S., Nachtigal, P.

Get full text